Jiaojiao Wu, Ying Yan, Hua Wei. Advances of radionuclide imaging in the diagnosis of hyperparathyroidism[J]. Int J Radiat Med Nucl Med, 2023, 47(8): 503-508. DOI: 10.3760/cma.j.cn121381-202211001-00326
Citation: Jiaojiao Wu, Ying Yan, Hua Wei. Advances of radionuclide imaging in the diagnosis of hyperparathyroidism[J]. Int J Radiat Med Nucl Med, 2023, 47(8): 503-508. DOI: 10.3760/cma.j.cn121381-202211001-00326

Advances of radionuclide imaging in the diagnosis of hyperparathyroidism

  • Hyperparathyroidism is a metabolism disorder of calcium and phosphorus caused by excessive parathyroid hormone. Surgery is a conventional and most effective treatment method. Accurate preoperative localization and characterization are very critical for successful parathyroidectomy. Most studies have shown that radionuclide imaging plays an important role in preoperative parathyroid localization diagnosis. In particular, new imaging agents (such as 18F-fluoromethyl choline) have good development prospects. This article summarizes the research progress of parathyroid SPECT and PET imaging and different radioactive imaging tracers in the diagnosis of hyperparathyroidism.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return